Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
University of Maryland Medical System.
Histamine-2 receptor antagonists have been available for fifteen years for the treatment of peptic ulcer disease and related disorders. While very safe, clinicians need to know correct dosing guidelines, drug interactions, and side effect profiles. Long-term therapy should be reserved for patients at high risk of recurrence.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on